Expression profiling of Ewing sarcoma cell lines exposed to 5nM Pladienolide B (PlaB) for 24 hours
Ontology highlight
ABSTRACT: Identification of genes and pathways altered by PlaB, a bacterial natural product that acts as a spliceosome modulator by targeting the SF3b subunit of the spliceosome SKNMC, TC32, TC71, and RD-ES Ewing sarcoma cell lines were treated with 0.1% (v/v) DMSO vehicle or 5nM PlaB for 24 hours. Three samples in each group were analyzed.
ORGANISM(S): Homo sapiens
SUBMITTER: Suntae Kim
PROVIDER: E-GEOD-67548 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA